Cargando…
Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288389/ http://dx.doi.org/10.1186/2051-1426-2-S3-P105 |
| _version_ | 1782351961792708608 |
|---|---|
| author | Huseni, Mahrukh Totpal, Klara Du, Changchun Dalpozzo, Katie Zhu, Jing Rishipathak, Deepali McNamara, Erin Jonshtone, Bernadette Hegde, Priti S Rhee, Ina Damico-Beyer, Lisa Kim, Jeong |
| author_facet | Huseni, Mahrukh Totpal, Klara Du, Changchun Dalpozzo, Katie Zhu, Jing Rishipathak, Deepali McNamara, Erin Jonshtone, Bernadette Hegde, Priti S Rhee, Ina Damico-Beyer, Lisa Kim, Jeong |
| author_sort | Huseni, Mahrukh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288389 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42883892015-01-15 Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models Huseni, Mahrukh Totpal, Klara Du, Changchun Dalpozzo, Katie Zhu, Jing Rishipathak, Deepali McNamara, Erin Jonshtone, Bernadette Hegde, Priti S Rhee, Ina Damico-Beyer, Lisa Kim, Jeong J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288389/ http://dx.doi.org/10.1186/2051-1426-2-S3-P105 Text en Copyright © 2014 Huseni et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Huseni, Mahrukh Totpal, Klara Du, Changchun Dalpozzo, Katie Zhu, Jing Rishipathak, Deepali McNamara, Erin Jonshtone, Bernadette Hegde, Priti S Rhee, Ina Damico-Beyer, Lisa Kim, Jeong Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models |
| title | Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models |
| title_full | Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models |
| title_fullStr | Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models |
| title_full_unstemmed | Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models |
| title_short | Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models |
| title_sort | anti-tumor efficacy and biomarker evaluation of agonistic anti-ox40 antibodies in preclinical models |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288389/ http://dx.doi.org/10.1186/2051-1426-2-S3-P105 |
| work_keys_str_mv | AT husenimahrukh antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT totpalklara antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT duchangchun antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT dalpozzokatie antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT zhujing antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT rishipathakdeepali antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT mcnamaraerin antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT jonshtonebernadette antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT hegdepritis antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT rheeina antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT damicobeyerlisa antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels AT kimjeong antitumorefficacyandbiomarkerevaluationofagonisticantiox40antibodiesinpreclinicalmodels |